US EditionAvalo Reports 2024 Financial Results and Recent Business Updates
Summary by Hastings Tribune
1 Articles
1 Articles
All
Left
Center
1
Right
Avalo Reports 2024 Financial Results and Recent Business Updates
Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026Appointed Jennifer Riley as Chief Strategy OfficerCash on hand of approximately $135 million as of December 31, 2024 expected to provide runway into…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
